All sites C00-96,D32-33,D42-43,D45-47,D76 705 92.4 1.7 1.6 0.5 3.8
Mouth, pharynx C00-14 17 100.0 - - - -
  Lip C00 3 100.0 - - - -
  Tongue C02 3 100.0 - - - -
  Mouth, other C03-06 5 100.0 - - - -
  Salivary glands C07-08 1 100.0 - - - -
  Pharynx C01,C09-14 6 100.0 - - - -
Digestive organs C15-26 146 89.7 1.2 3.3 1.0 4.8
  Oesophagus C15 9 91.1 - 2.2 - 6.7
  Stomach C16 16 98.7 - - - 1.3
  Small intestine C17 3 100.0 - - - -
  Colon C18 47 97.9 - 0.9 0.4 0.9
  Rectum, rectosigmoid C19-20 29 96.6 - - 0.7 2.7
  Anus C21 1 100.0 - - - -
  Liver C22 13 85.9 1.6 6.3 1.6 4.7
  Gallbladder, bile ducts C23-24 3 76.5 - 17.6 - 5.9
  Pancreas C25 24 61.9 6.8 11.9 3.4 16.1
  Other digestive organs C26 2 80.0 - - - 20.0
Respiratory organs C30-39 76 83.0 6.5 3.9 - 6.5
  Nose, sinuses C30-31 - - - - - -
  Larynx, epiglottis C32 6 100.0 - - - -
  Lung, trachea C33-34 69 81.8 7.2 4.0 - 6.9
  Mediastinum, pleura C38 0 50.0 - 50.0 - -
Bone C40-41 1 100.0 - - - -
Melanoma of the skin C43 27 100.0 - - - -
Skin, non-melanoma C44 39 99.5 0.5 - - -
Mesothelioma C45 3 100.0 - - - -
Autonomic nervous system C47 0 100.0 - - - -
Soft tissues C48-49 4 90.0 - 5.0 - 5.0
Breast C50 1 100.0 - - - -
Male genital organs C60-63 230 99.4 - - 0.1 0.5
  Prostate C61 222 99.5 - - 0.1 0.4
  Testis C62 5 95.8 - - - 4.2
  Other male genital C60,C63 3 100.0 - - - -
Urinary organs C64-68 66 93.6 1.5 1.2 0.6 3.0
  Kidney C64 21 89.4 - 1.9 1.0 7.7
  Bladder and urinary tract2 C65-68 45 95.6 2.2 0.9 0.4 0.9
Eye C69 0 50.0 - - 50.0 -
Brain, central nervous system C70-72,D32-33,D42-43 17 85.9 - 4.7 - 9.4
Thyroid gland C73 4 95.5 - - - 4.5
Other endocrine glands C74-75 0 100.0 - - - -
Illdefined or unknown C76,C80 11 69.6 1.8 10.7 3.6 14.3
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 60 77.7 6.6 1.3 1.3 13.0
  Hodgkin lymphoma C81 5 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 25 99.2 0.8 - - -
  Malignant immunoproliferative diseases C88 1 66.7 33.3 - - -
  Myeloma and other plasma cell tumors C90 9 54.5 11.4 6.8 6.8 20.5
  Leukaemia C91-95 13 62.1 18.2 1.5 - 18.2
  Myelodysplastic syndromes D46 5 50.0 4.2 - - 45.8
  Myeloproliferaitive neoplasms D45,D47 3 38.5 - - 7.7 53.8
Not included above
  Basal cell carcinoma of the skin 167 99.9 0.1 - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.